≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_HEPATOCELLU_CARC_EXALLC for full statistics.

Hepatocellular carcinoma

EFO Endpoint Browser

C3_HEPATOCELLU_CARC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C22.0&
  • Cancer registry: Topography ICD-O-3 — C22
  • Cancer registry: Morphology ICD-O-3 — 817[0-5]
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

695

4. Check minimum number of events

None

695

5. Include endpoints

None

695

6. Filter based on genotype QC (FinnGen only)

695

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF8

Similar endpoints

↥

List of similar endpoints to Hepatocellular carcinoma based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 695 94 601
Unadjusted period prevalence (%) 0.23 0.03 0.26
Median age at first event (years) 72.93 74.32 72.71

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
635
Matched controls
6348
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
323.0
503
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
14052.4
323.0
600
5
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
83.8
203.9
224
41
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
96.3
201.6
217
34
198
Kela drug reimbursment
Sorafenib
2091.7
168.6
156
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
244.2
135.6
135
7
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
+∞
120.8
112
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
69.5
120.6
137
25
130
Kela drug reimbursment
Malignant tumour
10.2
119.0
273
437
L01XE05
ATC
[U] sorafenib; oral
1340.3
117.6
111
*
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
41.2
96.5
121
36
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.4
83.7
191
278
Z51.5
ICD-10 Finland
Palliative care
9.3
79.1
181
262
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
54.3
71.8
85
18
323
Kela drug reimbursment
Sorafenib
+∞
61.5
58
*
N02AA05
ATC
oxycodone; systemic
4.9
60.8
246
725
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
634.6
59.7
58
*
R18
ICD-10 Finland
Ascites
24.6
58.9
84
39
C03DA01
ATC
spironolactone; oral
5.4
57.7
205
519
JN4CD
NOMESCO Finland
Very extensive body CT
9.1
55.1
123
163
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
37.3
50.2
64
19
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
14.0
44.5
78
63
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
9.2
43.8
96
121
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
20.3
43.8
66
36
Z94.4
ICD-10 Finland
Liver transplant status
161.1
43.4
45
*
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
+∞
43.2
41
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
42.1
40
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
213.0
39.3
40
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
12.0
36.9
69
64
A03FA01
ATC
metoclopramide; systemic, rectal
3.6
36.7
206
755
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
36.3
165
506
103
Kela drug reimbursment
Diabetes, insulin-treated
3.0
36.1
301
1462
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
17.9
35.7
56
34
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
70.9
35.4
40
6
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
33.1
277
1327
127
Kela drug reimbursment
Transplant complication
23.5
32.2
46
21
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.3
31.5
104
228
A10BA02
ATC
metformin; oral
2.8
31.5
295
1505
3019
Kela drug reimbursment
Lenvatinib
+∞
30.5
29
*
C03CA01
ATC
furosemide; systemic
2.6
29.5
339
1927
L01EX02
ATC
sorafenib; oral
+∞
29.4
28
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.8
29.2
264
1301
1508
Kela drug reimbursment
Lenvatinib
+∞
28.3
27
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
25.2
27.3
38
16
K76.9
ICD-10 Finland
Liver disease, unspecified
22.4
25.0
36
17
L04AA06
ATC
mycophenolic acid; systemic
14.4
24.9
42
31
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
36.1
24.5
31
9
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
39.3
24.1
30
8
A06AD11
ATC
lactulose; oral
2.8
23.0
177
770
K92.0
ICD-10 Finland
Haematemesis
6.7
22.9
60
98
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
124.5
22.7
24
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.6
22.3
82
200
L01EX08
ATC
lenvatinib; oral
+∞
22.0
21
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.4
21.7
68
139
176
Kela drug reimbursment
Regorafenib
113.8
20.7
22
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.6
20.1
73
175
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
11.9
19.7
36
32
D77
ICPC
Malignant digestive neopl other/NOS
25.5
19.7
27
11
A07AA11
ATC
rifaximin; oral
108.4
19.7
21
*
N02AX02
ATC
tramadol; systemic, rectal
2.2
18.9
322
2054
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
18.8
111
401
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
25.9
18.3
25
10
L04AD01
ATC
ciclosporin; systemic
11.9
18.2
33
29
A10AE04
ATC
insulin glargine; parenteral
3.1
18.1
110
404
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
+∞
17.8
17
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.3
17.5
211
1142
T90
ICPC
Diabetes non-insulin dependent
2.3
17.1
207
1119
A05AA02
ATC
ursodeoxycholic acid; oral
14.6
16.9
28
20
A10BB12
ATC
glimepiride; oral
2.9
16.9
111
429
JN4AD
NOMESCO Finland
Body CT examination
3.3
16.8
92
311
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
16.7
16
*
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
174.4
16.6
17
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
25.2
16.1
22
9
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
15.8
214
1209
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
61.6
15.8
18
*
JN4BD
NOMESCO Finland
Extensive body CT
2.7
15.7
120
505
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
19.8
15.6
23
12
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
87.3
15.6
17
*
D13.4
ICD-10 Finland
Benign neoplasm: Liver
163.8
15.5
16
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.3
15.5
83
279
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
+∞
14.6
14
*
JJ5AT
NOMESCO Finland
NA
82.0
14.6
16
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
82.0
14.6
16
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.1
14.5
82
286
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.4
14.3
142
690
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
43.5
14.2
17
*
A10BH01
ATC
sitagliptin; oral
2.7
14.0
101
410
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
14.0
13.8
23
17
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.9
13.6
86
323
PC2SC
NOMESCO Finland
Liver angiography with X-ray
+∞
13.6
13
*
K72.1
ICD-10 Finland
Chronic hepatic failure
26.4
13.4
18
7
JJB10
NOMESCO Finland
Atypcal resection of liver
41.0
13.2
16
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.8
13.0
43
94
D97
ICPC
Liver disease NOS
19.5
13.0
19
10
L01XE21
ATC
[U] regorafenib; oral
71.3
12.6
14
*
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
132.5
12.5
13
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
7.7
12.3
28
38
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
27.3
12.1
16
6
TK800
NOMESCO Finland
Hemodialysis
5.2
11.9
36
72
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
11.8
162
902
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
122.1
11.5
12
*
A98
ICPC
Health maint/preventive medicine
0.5
11.4
374
4597
I81
ICD-10 Finland
Portal vein thrombosis
15.4
11.4
18
12
369
Kela drug reimbursment
Regorafenib
44.1
11.0
13
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
9.8
10.8
21
22
C10AA05
ATC
atorvastatin; oral
0.5
10.5
131
2106
SPAT1262
SPAT
Handing over of treatment supplies
2.0
10.5
152
862
L01XE29
ATC
[U] lenvatinib; oral
+∞
10.4
10
*
A10AE05
ATC
insulin detemir; parenteral
3.1
10.4
58
198
WZC30
NOMESCO Finland
Teaching
2.3
10.3
96
449
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
10.2
304
2193
C07AA05
ATC
propranolol; systemic
2.3
10.1
97
456
A02BC02
ATC
pantoprazole; systemic
1.7
9.9
387
3018
K70.4
ICD-10 Finland
Alcoholic hepatic failure
26.5
9.8
13
5
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
9.8
9.8
19
20
205
Kela drug reimbursment
Chronic hypertension
1.7
9.7
265
1857
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
9.6
89
412
K92.1
ICD-10 Finland
Melaena
2.7
9.6
67
268
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
15.3
9.5
15
10
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
30.5
9.4
12
*
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
+∞
9.4
9
*
1550A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary
+∞
9.4
9
*
JJA20
NOMESCO Finland
Open biopsy of liver
22.1
9.4
13
6
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.2
9.2
102
513
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.3
9.2
27
53
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.5
9.0
41
123
TJA10
NOMESCO Finland
Laparocentesis
24.4
8.9
12
5
XX4BW
NOMESCO Finland
NA
24.4
8.9
12
5
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
14.3
8.7
14
10
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
50.7
8.7
10
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
10.2
8.6
16
16
JJB20
NOMESCO Finland
Excision of single segment of liver
91.2
8.4
9
*
K70.1
ICD-10 Finland
Alcoholic hepatitis
13.0
8.4
14
11
L01EX05
ATC
regorafenib; oral
+∞
8.3
8
*
K74.0
ICD-10 Finland
Hepatic fibrosis
+∞
8.3
8
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.8
8.2
52
196
WX402
NOMESCO Finland
General anaesthesia
2.1
8.1
89
449
K70.0
ICD-10 Finland
Alcoholic fatty liver
9.1
8.1
16
18
E66.00
ICD-10 Finland
Metabolic syndrome
3.1
8.0
43
146
A10BB01
ATC
glibenclamide; oral
2.5
7.7
62
267
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.4
7.7
31
738
JJA43
NOMESCO Finland
Destruction of lesion of liver
45.5
7.7
9
*
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
7.7
134
2006
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
7.6
35
792
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.4
7.6
65
291
ZXC40
NOMESCO Finland
Use of ultrasound
18.6
7.6
11
6
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
7.6
103
565
A10BG03
ATC
pioglitazone; oral
3.5
7.5
33
97
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
7.5
166
1073
UJF32
NOMESCO Finland
Coloscopy
1.7
7.4
179
1192
A04AA01
ATC
ondansetron; systemic, rectal
2.7
7.3
48
186
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
+∞
7.3
7
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
5.3
7.3
21
41
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
7.2
130
789
J01MA12
ATC
levofloxacin; systemic
1.7
7.1
152
971
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.2
7.0
35
114
B01AB10
ATC
tinzaparin; parenteral
2.5
7.0
54
228
R4110
NOMESCO Finland
Physiotherapy
1.7
6.9
161
1055
L04AX01
ATC
azathioprine; systemic
3.5
6.8
30
89
K72.9
ICD-10 Finland
Hepatic failure, unspecified
16.9
6.8
10
6
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
16.9
6.8
10
6
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
6.8
29
677
A10BD07
ATC
metformin and sitagliptin; systemic
2.8
6.7
40
148
B01AB05
ATC
enoxaparin; parenteral
1.6
6.7
199
1394
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.8
6.6
42
158
R50.9
ICD-10 Finland
Fever, unspecified
1.9
6.6
99
563
K83.0
ICD-10 Finland
Cholangitis
4.0
6.4
24
62
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
6.4
112
671
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
6.3
95
542
K76.89
ICD-10 Finland
Other specified diseases of liver
18.2
6.3
9
5
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
+∞
6.3
6
*
C22.2
ICD-10 Finland
Malignant neoplasm: Hepatoblastoma
+∞
6.3
6
*
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
4.0
6.2
23
59
E83.1
ICD-10 Finland
Disorders of iron metabolism
27.0
6.2
8
*
A79
ICPC
Malignancy NOS
5.1
6.2
18
36
WW200
SPAT
NA
0.2
6.2
5
274
J01MA02
ATC
ciprofloxacin; systemic
1.5
6.2
264
2011
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.3
6.1
29
92

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768441) Liver Pathology biopsy report
161
32
65.18
287.08
1.9
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
229
231
14.29
213.40
3.9
3.9
u/ml
313.0
17609.6
0.81
204
194
(3023183) Ammonium ion [Moles/volume] in Plasma
194
161
16.33
203.34
5.1
2.4
umol/l
42.2
32.4
4.07
170
131
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
323
628
8.74
177.36
3.9
4.4
ug/l
3.8
33.6
1.58
280
529
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
291
520
8.91
171.85
6.5
2.2
g/l
0.2
0.2
6.23
280
477
(3007566) Smooth muscle Ab [Titer] in Serum
143
111
15.96
154.09
1.5
1.1
titre
56.4
87.0
—
11
10
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
67
11
67.30
121.59
5.6
3.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
118
128
10.90
101.32
2.1
3.8
u/ml
34.2
377.9
1.07
111
117
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
251
638
5.59
97.72
12.6
2.8
umol/l
12.1
11.0
0.35
235
575
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
60
17
38.53
96.43
4.7
1.9
%
81.4
102.0
1.36
60
17
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
194
403
6.29
93.95
1.8
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
189
393
6.23
91.25
1.8
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
59
22
29.21
87.13
4.9
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
177
422
5.29
72.25
2.8
1.8
%
1.6
1.7
1.44
162
330
(3020779) Urea [Moles/volume] in Serum or Plasma
217
633
4.53
68.76
13.9
7.5
mmol/l
9.0
11.6
6.32
207
597
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
43
22
20.77
55.89
2.4
2.0
e6/l
1009.6
4339.8
0.77
30
15
(3024471) HLA-A [Type]
37
13
30.01
55.31
1.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
40
19
22.28
53.59
2.4
2.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
36
13
29.15
53.30
1.3
6.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
36
13
29.15
53.30
1.0
1.2
—
—
—
0
0
(4035726)
163
457
4.35
53.24
1.7
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
46
34
14.42
49.78
1.4
1.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
327
1565
3.06
45.31
14.1
3.2
u/l
66.3
37.3
3.62
318
1489
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
43
39
11.69
41.01
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
43
40
11.39
40.33
2.3
2.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
291
1389
2.88
39.27
17.3
4.2
%
74.6
81.2
4.90
281
1363
(3044007) Cell count panel - Peritoneal fluid
32
19
17.61
38.65
2.5
1.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
77
153
5.54
37.61
6.4
2.8
mg/l
1.8
1.9
0.24
70
137
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
63
105
6.50
36.88
1.3
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
418
2463
2.75
36.64
17.9
5.1
g/l
31.3
34.2
17.69
398
2286
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
54
87
6.65
32.60
1.3
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
41
48
9.01
32.55
1.2
1.1
titre
73.3
88.6
—
9
7
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
202
870
2.86
32.04
2.7
2.8
%
25.5
22.6
1.38
183
746
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
53
86
6.59
31.77
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
92
243
4.21
31.74
1.4
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
51
82
6.63
30.83
1.2
1.2
u/ml
422.7
298.1
1.19
39
45
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
441
2810
2.56
30.71
26.1
6.5
umol/l
22.7
13.1
8.23
426
2669
(3028026) IgM [Mass/volume] in Serum or Plasma
102
307
3.72
29.23
1.5
1.7
g/l
1.8
1.5
0.34
91
280
(3012095) Magnesium [Moles/volume] in Serum or Plasma
209
955
2.70
29.23
5.2
3.5
mmol/l
0.8
0.8
4.89
200
884
(3004789) Transferrin [Mass/volume] in Serum or Plasma
202
917
2.70
28.53
2.7
2.7
g/l
2.3
2.2
1.01
189
847
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
24
15
16.54
28.11
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
24
15
16.54
28.11
1.1
1.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
303
1678
2.43
27.97
6.2
2.5
u/l
57.9
56.9
0.12
290
1554
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
64
141
4.90
27.65
1.8
2.2
%
64.1
86.8
7.34
64
132
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
17
14.59
26.32
1.2
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
53
104
5.43
26.10
1.3
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
404
2592
2.33
25.93
20.4
11.9
inr
1.3
1.4
1.36
107
721
(44816559) Phosphatidylethanol [Mass/volume] in Blood
45
77
6.18
25.56
2.3
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
110
379
3.26
25.41
2.1
2.6
g/l
13.5
11.1
4.01
101
345
(3026692) Albumin [Mass/volume] in Peritoneal fluid
24
19
13.05
24.70
1.9
1.2
g/l
8.6
15.2
2.11
18
11
(3022948) Iron [Moles/volume] in Serum or Plasma
202
991
2.46
23.70
2.7
2.7
umol/l
13.3
12.3
0.96
194
919
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
53
114
4.95
23.51
11.6
5.4
iu/ml
977.6
250.1
0.89
25
17
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
28
33
8.80
22.02
1.0
1.0
mg/l
284.6
290.0
0.09
23
27
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
121
488
2.79
20.97
4.1
2.5
u/l
29.9
34.5
0.81
113
420
(4281824)
27
33
8.47
20.63
1.1
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
26
36
7.46
17.91
1.0
1.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
115
504
2.54
16.69
1.5
1.3
titre
320.0
400.4
0.44
26
112
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
402
2856
1.97
16.62
13.4
3.2
u/l
192.9
60.6
25.61
382
2602
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
164
2784
0.46
16.57
3.3
4.7
%
23.6
21.7
0.79
65
1466
(3044640) Blood type and Crossmatch panel - Blood
278
1771
1.95
15.60
4.3
2.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
162
851
2.18
15.42
8.7
6.2
mmol/l
1.1
1.0
0.45
150
780
(3002032) Base excess in Venous blood by calculation
127
619
2.29
14.44
4.1
4.1
mmol/l
0.9
1.8
1.73
91
484
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
46
132
3.66
13.98
1.8
2.4
%
212.1
209.9
0.05
46
123
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
32
70
4.74
13.89
1.2
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
220
1342
1.94
13.69
4.4
2.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
106
1975
0.45
12.83
2.0
3.3
ug/l
0.8
0.8
0.00
64
1410
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
246
3467
0.55
12.37
3.9
5.5
ug/l
2.2
4.7
1.30
190
3049
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
341
2455
1.76
12.00
7.9
4.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
123
642
2.11
11.66
1.4
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
19
30
6.48
11.60
1.1
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
11
11.08
11.09
1.1
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
280
1946
1.73
10.84
5.8
4.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
27
65
4.28
10.44
1.1
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
10
11.16
10.18
1.1
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
50
186
2.82
9.95
2.2
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
13
9.38
9.89
1.1
1.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
372
2856
1.65
9.49
15.4
9.0
e9/l
4.2
4.4
0.76
342
2486
(3000991) Gas panel - Venous blood
104
554
2.03
9.24
7.7
9.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
274
2.43
9.18
2.9
2.4
u/ml
0.2
0.4
3.83
37
154
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
83
407
2.18
9.15
3.7
3.3
ml/min/173m2
63.7
56.1
0.72
45
189
(3016650) Hepatitis A virus Ab [Presence] in Serum
26
68
3.93
9.03
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
25
6.11
8.68
1.7
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
380
4595
0.62
8.68
6.1
4.8
mmol/l
4.1
4.2
3.23
335
4155
(46235355) HIV 1 and 2 tests - Meaningful Use set
92
484
2.04
8.44
1.4
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
114
649
1.90
8.33
4.7
3.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
396
4723
0.62
8.24
6.2
5.4
mmol/l
2.4
2.5
1.71
345
4226
(3018418) pH of Serum or Plasma
237
1670
1.64
8.19
6.7
4.5
ph
7.4
7.4
0.05
60
323
(3042936) Bacteria identified in Isolate by Culture
146
903
1.78
8.17
2.8
2.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
393
4676
0.63
7.84
5.6
5.1
mmol/l
6.7
6.2
7.44
339
4142
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
380
4541
0.64
7.56
6.0
4.7
mmol/l
1.2
1.3
12.86
331
4054
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
353
2793
1.54
7.12
10.6
7.6
mmol/l
1.2
1.2
4.69
297
2328
(3014111) Lactate [Moles/volume] in Serum or Plasma
99
568
1.87
7.03
6.6
8.0
mmol/l
2.1
1.5
2.11
92
540
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
85
466
1.94
6.92
1.8
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
183
1263
1.61
6.67
3.7
3.1
mosm/kgh2o
562.5
576.5
0.39
167
1074
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
382
4510
0.66
6.60
39.4
17.7
ml/min/173m2
73.5
71.8
0.67
346
3792
(3012501) Base excess in Blood by calculation
37
147
2.60
6.54
7.4
4.8
mmol/l
1.4
2.5
2.78
24
97
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
327
2577
1.51
6.52
9.6
6.7
mmol/l
1.2
1.2
5.29
316
2312
(42870588) Differential panel, method unspecified - Blood
238
1758
1.54
6.41
7.6
5.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
69
362
2.01
6.37
11.2
10.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
372
4401
0.67
6.34
5.6
4.3
mmol/l
1.4
1.3
2.61
325
3906
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
18
47
3.91
6.29
1.0
1.1
u/l
43.9
47.4
0.17
13
31
(3013826) Glucose [Moles/volume] in Serum or Plasma
399
3292
1.50
6.27
12.4
5.4
mmol/l
7.6
7.0
5.00
383
3115
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
72
1249
0.53
6.26
2.1
1.7
mmol/l
1.8
1.3
2.91
67
1008
(3007164) IgA [Mass/volume] in Serum or Plasma
119
748
1.71
6.19
1.6
1.4
g/l
4.7
2.8
7.29
98
447
(3010421) pH of Blood
41
178
2.39
6.04
7.1
4.5
ph
7.4
7.4
0.13
36
143
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
429
0.24
5.95
1.1
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
392
4548
0.68
5.60
10.3
6.8
mmol/mol
45.2
41.6
6.14
349
4122
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
23
77
3.06
5.57
1.1
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
23
78
3.02
5.46
2.9
1.9
%
89.6
89.2
0.11
23
78
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
123
806
1.64
5.44
8.8
7.6
kpa
5.0
5.1
0.38
117
764
(3027801) Oxygen [Partial pressure] in Arterial blood
123
807
1.64
5.41
8.8
7.6
kpa
12.2
11.5
0.88
117
766
(3010813) Leukocytes [#/volume] in Blood
465
5212
0.67
5.38
56.0
27.2
e9/l
6.9
7.1
0.88
440
5020
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
158
2171
0.65
5.38
2.4
2.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
465
5211
0.67
5.36
56.5
27.4
g/l
123.9
134.0
27.55
444
5093
(3026361) Erythrocytes [#/volume] in Blood
465
5210
0.68
5.34
55.9
27.2
e12/l
4.1
4.4
19.25
441
5019
(3035941) MCH [Entitic mass]
465
5209
0.68
5.32
55.6
27.1
pg
30.4
30.6
1.18
444
5095
(3024731) MCV [Entitic volume]
465
5209
0.68
5.32
55.8
27.1
fl
91.5
92.0
0.85
445
5097
(3007461) Platelets [#/volume] in Blood
465
5209
0.68
5.32
56.0
27.2
e9/l
193.1
230.0
15.27
442
5045
(3002256) Pathology report gross observation
108
691
1.67
5.24
1.3
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
122
808
1.62
5.16
8.8
7.7
mmol/l
0.2
1.2
1.87
96
609
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
80
473
1.78
5.14
6.0
3.9
mmol/l
1.2
1.2
1.23
74
406
(1616796) Gas panel - Central venous blood
34
147
2.38
5.09
5.2
4.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
99
1490
0.61
4.98
1.7
1.7
nmol/l
16.2
19.4
1.62
85
1265
(40758558) Short blood count panel - Blood
170
1232
1.50
4.81
13.4
6.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
243
1889
1.44
4.80
4.5
4.0
mg/mmol
9.5
10.3
0.13
176
1275
(3009508) Creatinine [Moles/volume] in Urine
231
1779
1.45
4.80
3.6
3.2
mmol/l
7.4
7.8
0.72
183
1450
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
33
4.00
4.73
1.5
1.6
u/l
8.0
9.5
—
7
16
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
361
4193
0.71
4.68
4.8
4.2
mu/l
2.7
2.1
3.30
311
3696
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
5
14.12
4.58
1.0
1.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
94
602
1.65
4.54
2.8
3.2
ng/l
248.2
268.1
0.19
85
548
(3035637) Corticotropin [Mass/volume] in Plasma
16
49
3.32
4.49
1.4
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
42
210
2.06
4.46
8.8
6.3
mmol/l
2.1
1.4
0.69
36
178
(40768800) Prostate Pathology biopsy report
6
240
0.24
4.42
1.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
452
5037
0.71
4.40
32.9
11.4
u/l
43.8
25.9
24.68
436
4813
(3016502) Oxygen saturation in Arterial blood
110
738
1.58
4.39
9.3
7.9
%
95.5
94.8
0.46
105
704
(3023103) Potassium [Moles/volume] in Serum or Plasma
462
5122
0.71
4.28
46.1
22.7
mmol/l
4.1
4.0
1.21
442
4974
(3022217) INR in Platelet poor plasma by Coagulation assay
136
965
1.51
4.22
21.9
29.9
inr
1.4
1.5
0.45
14
116
(3019069) Monocytes/100 leukocytes in Blood
287
2339
1.39
4.20
9.3
6.1
%
9.6
9.2
1.29
268
2175
(3019550) Sodium [Moles/volume] in Serum or Plasma
462
5113
0.71
4.14
45.8
22.5
mmol/l
137.9
139.6
23.75
444
4965
(3002030) Lymphocytes/100 leukocytes in Blood
290
2374
1.38
4.11
9.1
6.0
%
22.5
24.7
2.60
269
2194
(3006504) Eosinophils/100 leukocytes in Blood
285
2328
1.38
4.09
9.0
5.8
%
2.8
2.9
0.36
267
2160
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
273
3275
0.73
4.04
4.3
3.3
pmol/l
14.6
15.1
2.73
239
2865
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
140
1013
1.48
3.94
3.3
3.4
e6/l
1.0
1.1
0.18
98
630
(36304419) Bacteria [Presence] in Urine
205
1596
1.40
3.88
4.3
3.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
277
2274
1.36
3.77
9.2
5.7
%
0.6
0.6
0.68
257
2117
(3018010) Neutrophils/100 leukocytes in Blood
281
2318
1.36
3.69
8.8
5.8
%
61.3
59.4
1.74
262
2160
(3019198) Lymphocytes [#/volume] in Blood
300
2501
1.35
3.67
8.6
5.6
e9/l
1.4
1.9
3.47
267
2184
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
449
3983
1.36
3.62
28.7
8.0
u/l
151.6
81.9
25.93
429
3720
(3006315) Basophils [#/volume] in Blood
295
2464
1.34
3.53
8.6
5.5
e9/l
0.0
0.0
0.42
256
2111
(3001604) Monocytes [#/volume] in Blood
294
2457
1.34
3.49
8.7
5.5
e9/l
0.6
0.6
0.01
256
2089
(40767503) Oxygen content in Capillary blood by calculation
29
141
2.10
3.36
4.0
2.7
%
15.4
15.8
—
10
79
(3012516) Albumin [Mass/volume] in Urine
220
1768
1.36
3.36
3.4
3.3
mg/l
326.9
293.7
0.04
165
1220
(3030467) Casts [#/volume] in Urine by Automated count
212
1694
1.36
3.36
4.3
3.6
e6/l
1.0
0.5
0.96
182
1334
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
149
1123
1.42
3.35
6.8
3.5
mmol/l
2.5
2.5
3.90
140
982
(3019060) Gas panel - Arterial blood
74
484
1.59
3.30
7.4
4.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
162
1243
1.40
3.28
1.6
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
41
228
1.85
3.27
4.1
3.1
g/l
0.2
0.3
0.82
31
96
(3013115) Eosinophils [#/volume] in Blood
301
2542
1.32
3.27
9.0
5.6
e9/l
0.2
0.2
1.20
262
2216
(3002582) Erythrocytes [#/volume] in Urine
230
1871
1.34
3.22
4.5
3.7
e6/l
89.1
123.5
0.32
195
1503
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
35
189
1.90
3.07
2.0
2.4
ug/min
140.9
86.6
0.33
23
109
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
62
396
1.62
3.06
1.7
1.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
49
296
1.71
2.99
8.1
4.9
%
0.9
0.9
0.32
43
274
(40761511) CBC panel - Blood by Automated count
449
4910
0.76
2.98
38.4
18.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
196
0.30
2.97
1.8
1.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
22
101
2.22
2.96
1.3
1.3
mmol/l
74.8
63.7
0.45
13
84
(1761868) Lipid panel - Serum or Plasma
100
1358
0.69
2.93
4.6
3.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
136
1046
1.37
2.69
3.1
3.2
e6/l
0.6
1.0
2.73
94
656
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
195
1585
1.32
2.68
2.9
2.2
mg/l
3.8
3.1
2.88
169
1353
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
38
623
0.59
2.65
1.1
1.3
iu/ml
16.1
38.8
3.52
13
193
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
15
4.70
2.60
1.3
1.5
ug/l
37.7
66.9
—
7
15
(40760892) CBC W Ordered Manual Differential panel - Blood
126
963
1.38
2.59
6.3
4.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
235
1.70
2.44
1.2
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
31
175
1.81
2.42
3.5
3.8
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
61
413
1.52
2.39
10.0
10.3
%
0.7
0.7
0.11
61
408
(3000850) Epithelial cells [#/volume] in Urine
164
1332
1.30
2.23
3.9
2.8
e6/l
5.3
3.5
1.38
156
1173
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
100
2.03
2.22
3.3
3.3
%
55.0
59.5
0.81
20
100
(40768804) Tissue Pathology biopsy report
223
1891
1.26
2.15
2.6
2.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
19
95
2.03
2.12
3.2
2.8
e9/l
3.6
4.7
1.44
19
95
(3004809) Band form neutrophils/100 leukocytes in Blood
20
102
1.99
2.12
2.8
3.8
%
2.2
1.6
0.19
14
87
(3015377) Calcium [Moles/volume] in Serum or Plasma
216
1829
1.26
2.11
7.2
3.6
mmol/l
2.3
2.3
3.15
203
1576
(3020630) Protein [Mass/volume] in Serum or Plasma
77
562
1.42
2.09
2.1
2.9
g/l
65.5
65.8
0.11
66
507
(3007853) Bacteria identified in Skin by Aerobe culture
92
693
1.38
2.08
1.6
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
10
5.03
2.07
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
38
584
0.63
2.06
1.1
1.3
u/ml
19.9
11.8
0.21
15
203
(40768446) Kidney Pathology biopsy report
6
15
4.03
2.04
1.0
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
236
2026
1.25
2.03
4.0
2.8
ug/l
193.8
185.4
0.17
218
1827
(3017446) Testosterone [Moles/volume] in Serum or Plasma
35
543
0.63
1.99
2.7
2.2
nmol/l
10.5
12.5
0.55
25
463
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
144
1173
1.29
1.91
4.2
4.2
ng/l
433.9
324.8
0.21
125
1028
(4024509)
0
51
0.00
1.89
0.0
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
22
3.20
1.88
1.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
34
2.67
1.87
2.1
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
71
524
1.40
1.83
1.5
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
14
66
2.14
1.83
1.5
2.4
ml
870.3
653.6
—
8
39
(3011397) Hemoglobin [Presence] in Urine by Test strip
89
1143
0.75
1.83
3.8
3.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
43
288
1.53
1.82
2.5
2.5
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
8
29
2.78
1.79
1.3
4.0
nmol/l
77.7
100.7
—
8
29
(3026493) Urate [Moles/volume] in Serum or Plasma
178
1501
1.25
1.77
4.6
3.1
umol/l
6348.1
7895.0
0.14
158
1263
(3017817) Protein [Mass] in Urine collected for unspecified duration
14
67
2.11
1.77
1.6
2.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
58
417
1.43
1.74
10.0
10.1
%
1.4
1.4
0.46
58
412
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
103
1.87
1.73
1.6
3.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
13
3.87
1.72
1.4
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
46
0.00
1.71
0.0
1.0
—
40.0
—
0
23
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
46
0.00
1.71
0.0
1.0
—
560.2
—
0
24
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
46
0.00
1.71
0.0
1.0
—
304.8
—
0
25
(4010399)
21
354
0.58
1.69
1.2
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
146
0.41
1.66
1.2
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
34
504
0.66
1.60
3.5
3.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
58
425
1.40
1.58
3.4
2.2
nmol/l
367.9
378.2
0.15
53
381
(3000494) Fungus identified in Specimen by Culture
81
627
1.33
1.57
2.1
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
331
3620
0.84
1.56
5.2
4.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
234
2056
1.21
1.55
5.0
4.2
e6/l
84.8
128.6
0.41
200
1581
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
247
2183
1.20
1.54
4.4
3.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
344
3746
0.84
1.53
50.2
25.1
g/l
331.1
332.2
1.13
336
3713
(3051651) Icteric interference index of Serum or Plasma
9
39
2.32
1.43
2.7
3.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
111
1.73
1.40
1.8
1.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
17
96
1.79
1.40
1.3
1.3
u/l
10.6
7.8
—
10
74
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
120
0.41
1.38
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
5
122
0.41
1.38
1.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
188
1637
1.20
1.36
3.2
3.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
75
1.88
1.35
2.1
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
54
2.05
1.33
2.0
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
151
1291
1.22
1.32
1.8
1.8
nmol/l
1175.4
1168.5
0.03
113
979
(3004451) EKG impression Narrative
9
43
2.11
1.30
1.1
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
34
2.37
1.29
2.1
1.2
promille
0.8
1.4
—
8
27
(3031040) Bacteria [#/volume] in Urine by Automated count
374
3470
1.17
1.25
4.9
4.8
e6/l
599.1
2165.1
—
7
73
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
25
2.41
1.24
1.3
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
16
264
0.60
1.24
2.1
2.5
—
18.3
—
0
11
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
122
1029
1.23
1.22
1.6
1.7
mg/l
3.2
1.6
1.62
102
820
(1761482) Bacteria [#/volume] in Urine by Culture
28
190
1.49
1.18
3.4
5.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
13
72
1.82
1.15
1.5
1.6
g/l
0.4
1.0
—
7
51
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
28
191
1.49
1.15
1.9
2.9
g/l
0.1
0.0
0.41
20
176
(4062490)
8
39
2.06
1.15
1.6
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
20
2.51
1.15
1.4
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
215
2386
0.86
1.11
1.9
2.2
pmol/l
83.5
90.9
1.37
100
1308
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
138
0.50
1.10
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
12
205
0.58
1.08
1.9
2.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
22
145
1.53
1.07
3.7
2.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
22
145
1.53
1.07
1.0
1.6
ug/g
341.1
255.1
1.13
12
90
(3013707) Erythrocyte sedimentation rate by Westergren method
336
3603
0.87
1.07
5.3
4.1
mm/h
23.6
14.8
8.69
300
3260
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
26
180
1.46
1.02
1.9
2.9
g/l
0.0
0.0
0.00
18
165
(40768806) Pleura Pathology biopsy report
16
99
1.63
1.00
2.2
1.6
—
—
—
0
0
(4034850)
9
159
0.56
0.99
23.6
13.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
49
1.85
0.99
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
375
3523
1.14
0.96
5.5
4.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
25
174
1.45
0.96
2.0
3.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
53
664
0.78
0.96
3.7
4.9
%
32.6
31.8
0.18
36
435
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
461
4819
0.87
0.95
39.7
19.0
mg/l
34.4
30.5
1.52
439
4003
(3002385) Erythrocyte distribution width [Ratio]
358
3804
0.88
0.95
53.7
22.9
%
15.2
14.0
28.86
350
3716
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
9
51
1.77
0.95
1.1
1.2
%
100.6
110.4
—
9
45
(3017354) Segmented neutrophils/100 leukocytes in Blood
11
62
1.79
0.94
2.3
3.5
%
63.0
54.0
—
6
48
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
92
776
1.21
0.94
2.1
1.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
15
93
1.63
0.94
2.3
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
120
0.50
0.94
1.3
2.5
—
—
—
0
0
(3020891) Body temperature
35
261
1.36
0.93
6.4
4.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
56
448
1.27
0.92
4.0
4.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
151
1.47
0.91
1.7
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
94
1.61
0.91
7.5
3.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
91
770
1.21
0.91
2.1
1.8
—
—
—
0
0
(3012565) Volume of 24 hour Urine
6
29
2.08
0.89
1.7
2.7
ml
1621.7
2001.7
—
6
24
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
127
1111
1.18
0.88
2.0
1.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
56
1.80
0.88
1.5
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
223
2433
0.88
0.87
4.5
3.9
estimate
0.0
0.0
0.00
47
457
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
8
43
1.87
0.87
1.1
1.1
—
238.5
—
0
12
(3002179) Metamyelocytes/100 leukocytes in Blood
50
399
1.27
0.85
5.7
4.1
%
0.5
0.6
0.26
20
120
(3019225) pH of Specimen
67
554
1.23
0.84
3.0
4.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
22
154
1.44
0.84
1.7
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
171
1.42
0.84
1.7
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
46
1.75
0.82
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
24
0.00
0.79
0.0
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
25
0.00
0.79
0.0
3.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
25
0.00
0.79
0.0
3.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
26
0.00
0.78
0.0
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
47
377
1.26
0.78
3.2
2.2
ug/g
206.9
147.8
0.69
32
313
(3018405) Lactate [Moles/volume] in Arterial blood
34
261
1.32
0.78
5.6
3.4
mmol/l
2.5
1.5
0.84
34
255
(3017181) Myelocytes/100 leukocytes in Blood
55
450
1.24
0.77
6.8
4.2
%
0.5
0.8
0.88
25
158
(4211845)
0
28
0.00
0.76
0.0
2.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
54
1.68
0.74
1.2
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
223
2410
0.89
0.73
4.5
3.9
estimate
0.0
0.0
0.00
54
472
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
39
1.80
0.72
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
56
1.61
0.72
1.2
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
43
345
1.26
0.72
1.6
1.9
g/l
1.1
1.5
2.64
36
298
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
24
177
1.37
0.71
2.0
3.0
g/l
0.0
0.0
0.00
17
165
(3024928) Oxygen saturation in Venous blood
20
143
1.41
0.70
2.2
2.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
143
1286
1.14
0.70
4.4
3.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
144
0.62
0.70
1.1
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
93
1.52
0.70
2.0
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
85
1.54
0.69
2.8
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
59
1.53
0.68
3.3
3.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
117
0.59
0.68
1.1
2.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
43
1.63
0.67
1.4
1.3
nmol/l
—
—
—
0
0
(4268621)
7
43
1.63
0.67
2.3
2.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
51
423
1.22
0.65
7.2
4.3
%
0.0
0.1
0.78
25
146
(36660697) Celiac disease serology panel - Serum
20
270
0.73
0.65
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
95
1077
0.86
0.65
5.9
4.4
kg/l
1.0
1.0
0.98
23
175
(3021601) Nitrite [Presence] in Urine by Test strip
222
2385
0.90
0.65
5.9
5.2
estimate
0.0
0.0
0.00
53
475
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
155
1.37
0.63
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
155
1.37
0.63
1.4
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
26
199
1.32
0.63
1.9
2.8
g/l
36.7
36.8
0.02
19
170
(3025159) Blasts/100 leukocytes in Blood
48
398
1.22
0.62
7.0
4.3
%
0.0
0.2
0.96
21
127
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
140
1268
1.13
0.62
1.9
1.8
pmol/l
422.2
9436212.9
0.79
109
1028
(3015235) Bicarbonate [Moles/volume] in Capillary blood
26
200
1.31
0.61
4.1
3.3
mmol/l
21.9
24.7
2.14
21
171
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
38
308
1.25
0.61
2.1
2.8
%
0.7
0.7
0.87
38
301
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
94
831
1.15
0.60
2.6
2.5
%
2.0
1.8
1.46
85
748
(3036670) Protein [Mass/volume] in Synovial fluid
0
21
0.00
0.60
0.0
1.1
—
37.4
—
0
13
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.7
—
2188.6
—
0
22
(3003740) Influenza virus B Ag [Presence] in Specimen
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
28
219
1.29
0.59
1.9
2.8
g/l
1.2
1.2
0.00
20
190
(4306422)
8
53
1.52
0.58
1.5
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
54
458
1.19
0.57
2.0
2.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
81
1.49
0.57
1.8
3.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
55
1.46
0.56
1.0
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
133
1.36
0.55
1.6
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
172
1857
0.90
0.55
3.1
2.2
nmol/l
72.8
77.1
1.06
152
1602
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
126
0.63
0.54
1.4
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
53
453
1.18
0.53
3.2
4.0
ph
7.4
7.4
—
5
57
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
40
1.50
0.51
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
11
75
1.47
0.51
1.3
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
87
778
1.14
0.49
1.2
1.2
u/ml
1.7
1.5
0.16
14
191
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
45
1.56
0.49
1.3
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
235
1.24
0.49
2.3
2.8
g/l
3.0
3.2
0.36
19
184
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
50
429
1.18
0.48
3.3
4.1
mmol/l
0.9
2.0
1.35
29
320
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
110
0.63
0.48
1.4
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
53
459
1.17
0.46
3.3
4.0
kpa
4.9
5.2
2.13
44
421
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
8
118
0.67
0.46
1.4
1.3
mg/l
424.9
538.5
—
8
110
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
49
1.43
0.46
1.4
1.3
nmol/l
2.8
0.6
—
7
43
(3017732) Neutrophils [#/volume] in Blood
24
297
0.80
0.45
1.9
3.2
e9/l
5.3
4.0
0.49
17
213
(3021589) Normoblasts [#/volume] in Blood
230
2176
1.09
0.45
23.1
10.6
e9/l
0.0
0.0
1.11
184
1782
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
23
184
1.26
0.44
1.6
1.5
—
197.1
—
0
7
(3019832) Treponema pallidum Ab [Presence] in Serum
9
129
0.69
0.43
1.2
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
30
360
0.83
0.43
3.7
3.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
57
1.41
0.42
3.1
1.8
—
—
—
0
0
(4146454)
10
70
1.43
0.42
2.5
2.5
—
—
—
0
0
(44806420)
5
33
1.52
0.41
3.8
2.5
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.3
—
38.4
—
0
5
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
26
213
1.23
0.41
1.3
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
17
0.00
0.40
0.0
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
34
1.47
0.40
2.2
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
34
1.47
0.40
2.2
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
104
0.67
0.39
1.0
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
115
1.31
0.39
1.3
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
195
2058
0.93
0.38
2.9
3.2
ng/l
1591.1
2114.7
0.53
171
1816
(3034860) Kappa light chains.free [Mass/volume] in Serum
28
234
1.20
0.38
2.2
3.7
mg/l
54.4
89.3
0.64
18
191
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
67
602
1.13
0.37
2.3
2.7
ug/l
7.7
7.2
0.06
55
523
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
37
1.35
0.37
5.0
3.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
28
235
1.20
0.36
2.2
3.7
mg/l
37.4
39.5
0.12
18
196
(3011648) Oxygen content in Venous blood
6
42
1.43
0.35
2.0
1.6
%
10.9
10.8
—
6
42
(3000330) Specific gravity of Urine by Test strip
36
311
1.17
0.35
3.7
4.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
255
1.18
0.35
2.3
2.8
g/l
7.4
7.3
0.05
19
186
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
74
1.36
0.32
2.4
2.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
47
1.28
0.32
1.5
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
47
1.28
0.32
1.5
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
96
0.73
0.31
2.3
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
98
0.71
0.31
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
98
0.71
0.31
2.3
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
84
1.31
0.30
1.3
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
61
669
0.90
0.29
12.9
9.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
62
1.29
0.28
1.6
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
233
1.17
0.28
1.9
2.9
g/l
14.3
10.6
1.87
19
200
(3000093) Morphology [Interpretation] in Blood Narrative
8
63
1.27
0.28
1.3
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
104
1.25
0.26
2.8
2.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
383
0.88
0.26
1.3
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
71
0.70
0.26
1.4
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
160
0.81
0.26
1.2
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
400
4086
0.95
0.26
40.7
20.5
%
35.7
38.7
6.40
244
2479
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
244
2358
1.05
0.25
4.6
4.4
ng/l
33.0
57.9
3.96
206
1887
(21494434) Karyotype in Bone marrow
9
73
1.24
0.25
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
21
179
1.18
0.25
1.1
1.1
iu/ml
12.8
106.5
—
5
63
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
11
137
0.80
0.24
2.0
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
255
1.14
0.24
2.3
2.8
g/l
4.3
3.7
1.36
19
181
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
255
1.14
0.24
2.3
2.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
82
0.73
0.24
1.0
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
37
332
1.12
0.23
2.6
4.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
92
0.76
0.22
1.1
1.4
—
—
—
0
0
(3013512) EKG study
179
1722
1.05
0.22
4.6
4.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
42
1.19
0.21
1.8
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
101
0.79
0.21
1.3
1.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
12
0.00
0.21
0.0
7.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
8
103
0.77
0.21
2.0
1.2
u/l
84.9
46.2
—
8
89
(3023410) Appearance of Cerebral spinal fluid
5
43
1.16
0.21
2.0
1.2
—
—
—
0
0
(3000492) Spirometry study
44
403
1.10
0.20
1.2
1.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
6
48
1.25
0.20
1.0
1.3
mu/l
564.6
36.3
—
6
42
(3029075) Extractable nuclear Ab panel - Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
2.2
—
0
5
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
229
0.87
0.20
1.1
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
49
1.23
0.20
2.5
2.6
—
—
—
0
0
(3035880) pH of Pleural fluid
6
52
1.16
0.19
1.0
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
40
368
1.09
0.17
3.9
3.0
e6/l
0.7
0.4
0.38
40
362
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
63
1.11
0.17
1.3
2.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
66
0.76
0.17
1.6
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
66
0.76
0.17
1.6
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
39
422
0.92
0.16
1.7
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
225
0.89
0.16
1.1
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
70
1.14
0.16
3.9
3.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
31
339
0.91
0.16
2.5
3.1
—
—
—
0
0
(44790047)
8
72
1.11
0.16
1.5
1.6
—
—
—
0
0
(44790048)
8
72
1.11
0.16
1.5
1.6
—
—
—
0
0
(44790049)
8
72
1.11
0.16
1.5
1.6
—
—
—
0
0
(44806118)
8
72
1.11
0.16
1.5
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
130
1.16
0.15
1.1
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
133
1372
0.96
0.13
4.9
4.1
estimate
0.0
0.0
0.50
41
440
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
108
0.83
0.13
1.2
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
9
109
0.82
0.13
1.4
1.9
pmol/l
202.1
223.1
—
9
101
(3037756) Immunofixation for Serum or Plasma
14
158
0.88
0.12
1.4
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
125
1.12
0.10
1.1
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
2.2
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
12
106
1.13
0.10
4.7
2.3
%
63.1
62.4
0.04
12
106
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
45
1.11
0.10
1.0
1.4
pmol/l
876.4
253.5
—
5
35
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
46
1.09
0.09
1.2
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
46
1.09
0.09
1.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
126
1.11
0.09
1.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
277
0.94
0.08
1.9
3.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
63
0.79
0.08
1.6
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
64
0.78
0.08
1.6
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
65
0.77
0.08
1.6
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
67
1.05
0.08
1.3
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
70
0.86
0.07
2.7
2.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
72
0.83
0.07
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
83
0.84
0.07
1.7
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
87
1.03
0.07
1.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
88
1.02
0.07
1.8
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
184
1866
0.98
0.06
4.8
4.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
21
197
1.07
0.06
1.0
1.8
u/l
49.6
36.1
1.33
14
171
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
26
247
1.05
0.05
1.3
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
188
1.07
0.05
1.5
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
277
1.05
0.05
1.4
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
151
0.93
0.05
1.3
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
100
1.10
0.05
1.9
2.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
173
1711
1.01
0.04
2.1
2.2
u/l
214.0
304.9
0.79
162
1589
(3043409) Potassium [Moles/volume] in Arterial blood
22
210
1.05
0.03
7.1
3.7
mmol/l
4.1
4.0
0.23
22
192
(3023520) Reticulocytes [#/volume] in Blood
63
621
1.02
0.02
2.5
2.7
e9/l
82.7
66.4
1.94
47
495
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
95
1.05
0.00
1.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
113
0.97
0.00
1.9
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
123
0.98
0.00
1.8
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
123
0.98
0.00
1.6
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
127
1.02
0.00
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
96.5
—
0
6
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
17.9
—
0
7
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.0
1.8
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
0.1
—
0
7
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.0
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.0
1.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
9.2
—
0
5
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
65
0.92
0.00
1.5
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
9
0.00
0.00
0.0
2.4
—
13.3
—
0
9
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
10.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
99
0.91
0.00
1.8
1.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
91
0.99
0.00
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
8.2
—
0
5
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_HEPATOCELLU_CARC – Hepatocellular carcinoma

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).